Wuppertal, North Rhine-Westphalia, Germany
Business Development and Alliance Management professional with 15 years of working in biotech and pharma. Strong Expertise in Strategy & Portfolio (Rx & OTC). Former CEO of a biotech oncological company. Proven track record of various international partnering deals in Pharma. Professional knowledge of global pharmaceutical markets.
Leading the Business Development Function for InflaRx with a focus on finding partnering options for company portfolio: - Regional parntering strategy for Gohibic (complement C5a targeting antibody) in ARDS (US, EU, ROW) - Strategic partnering options for vilobelimab (complement C5a targeting antibody) in Pyoderma Gangrenosum - Partnering opportunities for INF904 (C5AR1 targeting small molecule) in Immunodermatology and other areas of Inflammation -Market research and competitive intelligence for the products in the Immunology&Inflammation field
Leading the Business Development & Alliance Management division in the company during company transformation. Business development activities: - In-licensing/merge options for a late-stage assets with a high synergy to current portfolio - Development and implementation of commercialization and partnering strategy for company Phase 3 asset - In-licensing activities for early stage (preclinical, Phase I, Phase II ready) assets in anti-infectives area Innovation Management: - Supervision of the AiCubator - company's corporate incubator for innovative breakthrough approaches - Scouting activities and new ways of collaboration with academic institutes Alliance Management: -Alliance Management of company existing partnerships with commercial and scientific partnerships
Managing business development function within the company: - Partnering opportunities for company late-stage portfolio - In-licensing activities for early stage (preclinical, Phase I, Phase II ready) assets in anti-infectives area - Scouting activities and new ways of collaboration with academic institutes Alliance Management: - Alliance Management of partnership with Merck, Inc (MSD) in terms of development and commercial activities - Launch and management of AiCubator, company corporate incubator
External Innovation Lead: - R&D partnering with the focus on leading research and academic institutes - Exploring of partnering opportunities with early-stage start-ups (various types of collaboration) - Launch and management of CoLaborator Moscow - Bayer Incubator for innovative projects in Healthcare - Strategic scientific partnerships with leading medical research organizations in oncology, cardiovascular, ophthalmology, women's healthcare Project/alliance management activities - Alliance management of existing early stage partnerships - Localization strategy in Pharma - BD&L function support
Company strategy and portfolio management both in Rx and OTC areas Responsibility for all partnering deals for Bayer Healthcare: -Acquisitions -Licensing deals -Divestments Alliance Management Management of localization projects for Pharma and R&I
General management for biotech oncology company with one marketed drug and a diversified portfolio (both preclinical and clinical) Full scope of business development activities Strategy planning and portfolio structuring Development of partnership programs in oncology field R&D deals partnering with further alliance and project management Launch of personalized anticancer vaccine Supervision and licensing of local manufacturing facility for personalized vaccines
- Organization and management of project office for R&D projects in Pharma and Medtech - Launch of a new project evaluation approach within the project office - Pharmaceutical projects expertise (scientifically and financially, including financial modeling and business plan development) - Financing for startups (internal investments, external VC investments, and grant financing) - Startups management and supervision